Latest News about ABBV
Recent news which mentions ABBV
   Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
   
  
  
  October 03, 2024
  From Benzinga
 
   5 Best Dividend Growth Stocks to Buy in October
   
  
  
  October 02, 2024
  From Motley Fool
 From Benzinga
 
   Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
   
  
  
  September 27, 2024
  From Benzinga
 
   Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
   
  
  
  September 26, 2024
  From Benzinga
 
   AbbVie Says Pivotal Trial For Parkinson's Candidate Meets Its Primary Goal In Patients With Early Disease
   
  
  
  September 26, 2024
  From Benzinga
 
   Forget Novo Nordisk, Buy This Magnificent Dividend Stock Instead
   
  
  
  September 26, 2024
  From Motley Fool
 
   Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
   
  
  
  September 20, 2024
  From Benzinga
 
   Spotlight on AbbVie: Analyzing the Surge in Options Activity
   
  September 20, 2024
  Tickers 
   ABBV
  
  
  From Benzinga
 From Benzinga
 From Motley Fool
 
   TransDigm, BJ's Wholesale, AbbVie And More On CNBC's 'Final Trades'
   
  
  
  September 17, 2024
  From Benzinga
 
   Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
   
  
  
  September 16, 2024
  From Motley Fool
 
   Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
   
  
  
  September 14, 2024
  From Motley Fool
 
   3 Stocks to Buy and Hold Forever
   
  
  
  September 14, 2024
  From Motley Fool
 
   Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
   
  
  
  September 14, 2024
  From Motley Fool
 
   Is This Company Still a Strong Buy After Tripling the S&P 500's Returns?
   
  September 13, 2024
  Tickers 
   ABBV
  
  
  From Motley Fool
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.